Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation

Multiple myeloma (MM) has benefited from significant advancements in treatment that have improved outcomes and reduced morbidity. However, the disease remains incurable and is characterized by high rates of drug resistance and relapse. Consequently, methods to select the most efficacious therapy are...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Commun
Autors principals: Cetin, Arif E., Stevens, Mark M., Calistri, Nicholas L., Fulciniti, Mariateresa, Olcum, Selim, Kimmerling, Robert J., Munshi, Nikhil C., Manalis, Scott R.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5694762/
https://ncbi.nlm.nih.gov/pubmed/29151572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-017-01593-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars